PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923 This issue Cite

Erratum

The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum

Jingfeng Zhou, Bei Jin, Yanli Jin, Yizhi Liu, Jingxuan Pan Corresponding address

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 S. Xianlie Road, Guangzhou, 510060, China

✉ Corresponding author: Jingxuan Pan, M.D., Ph.D., State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 S. Xianlie Road, Guangzhou 510060, People's Republic of China, Phone: +86-20-37628262, E-mail: panjx2sysu.edu.cn More

Citation:
Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923. https://www.thno.org/v10p7401.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 7, 1447

 

In our article [1], there were one misplaced image in Fig. 2C and Fig. 6B, respectively. The corrected version of Figure 2C and Figure 6B are provided here.

 Figure 2C 

UM cells were exposed to niclosamide for 48 h, Western blot analysis of cytochrome c in the cytosolic extracts.

Theranostics Image
 Figure 6B 

Mel270 and Omm2.3 cells were treated with niclosamide (1 μmol/L) for 48 h, and the percentage of Aldefluor+ cells was determined by flow cytometry. Representative flow cytometry data and bar graph with SD from 3 independent experiments are shown. **, p< 0.01; ***, p< 0.001, Student's t test.

Theranostics Image

In addition, the description of the whole section regarding all the supported grants originally stated in the acknowledgements in the initially published version of this article [1] is replaced with: The study was supported by grant (Grant 2015A030312014 to J. Pan) from Natural Science Foundation of Guangdong Province.

The corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that these errors may have caused.

References

1. Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo. Theranostics. 2017;7(6):1447-1462 doi:10.7150/thno.17451

Author contact

Corresponding address Corresponding author: Jingxuan Pan, M.D., Ph.D., State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 S. Xianlie Road, Guangzhou 510060, People's Republic of China, Phone: +86-20-37628262, E-mail: panjx2sysu.edu.cn

Published 2020-6-10

Citation styles

APA
Zhou, J., Jin, B., Jin, Y., Liu, Y., Pan, J. (2020). The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics, 10(16), 7401-7402. https://doi.org/10.7150/thno.47923.

ACS
Zhou, J.; Jin, B.; Jin, Y.; Liu, Y.; Pan, J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020, 10 (16), 7401-7402. DOI: 10.7150/thno.47923.

NLM
Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923. https://www.thno.org/v10p7401.htm

CSE
Zhou J, Jin B, Jin Y, Liu Y, Pan J. 2020. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics. 10(16):7401-7402.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use